Last month, an advisory panel to the United States Food and Drug Administration (FDA) voted unanimously to recommend the approval of Epidiolex, an epilepsy medication with cannabidiol as the active ingredient. If the recommendation is accepted – as it most likely will be – Epidiolex will be the first cannabis-based medication to be available (in … Continue reading The FDA Recommends Cannabis-Derived Epilepsy Medication For Approval